183 related articles for article (PubMed ID: 15472900)
1. Apoptosis of circulating tumor cells in prostate cancer patients.
Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells predict survival in patients with metastatic prostate cancer.
Moreno JG; Miller MC; Gross S; Allard WJ; Gomella LG; Terstappen LW
Urology; 2005 Apr; 65(4):713-8. PubMed ID: 15833514
[TBL] [Abstract][Full Text] [Related]
3. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
6. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
7. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
8. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
[TBL] [Abstract][Full Text] [Related]
11. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
12. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
[TBL] [Abstract][Full Text] [Related]
14. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Danila DC; Heller G; Gignac GA; Gonzalez-Espinoza R; Anand A; Tanaka E; Lilja H; Schwartz L; Larson S; Fleisher M; Scher HI
Clin Cancer Res; 2007 Dec; 13(23):7053-8. PubMed ID: 18056182
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
[TBL] [Abstract][Full Text] [Related]
19. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
